The aim is for nras to be able to. Effective regulatory systems are an essential component of health systems and contribute to desired public health outcomes and innovation. The global surveillance and monitoring system for sf medical products was launched in july 2013
Sean Gatz (@sean_gatz) • Instagram photos and videos
Objectives its objective is to work with member states in improving the quantity, quality and analysis of accurate data concerning sf medical products, and to use that data in the better prevention, detection and response to those products, in order to protect public health
Improve reporting of sf medical products assess more accurately the scope, scale and harm caused by sf medical products.
Medical products may be subjected to various risks at different stages in the supply chain, for example, purchasing, storage, repackaging, relabelling, transportation and distribution. Regulation and prequalification progress towards enhancing regulatory practices related to medical products around the world is supported by capacity building, promoting regulatory convergence and harmonization. Regulating medical products medicines who plays a vital role in the regulation of medical products At the global level, who works to develop internationally recognized norms, standards and guidelines for medicine quality, safety and efficacy.
Who fact sheet on substandard and falsified medical products, including key facts, scope of the problem, impacts, challenges and who response. About us assistive technology medical devices essential medicines Who global benchmarking tools (gbt) for evaluation of national regulatory systems regulatory systems play a key role in assuring the quality, safety, and efficacy of medical products
